Anticoagulation practice in cardiac electrophysiology

Heart Rhythm

Volumn 3, Issue 3, 2006, Pages 372-374

  Shea, Julie B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; CLOPIDOGREL; DIGOXIN; DOFETILIDE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; PLACEBO; PROCAINAMIDE; PROPAFENONE; SOTALOL; THROMBIN INHIBITOR; VERAPAMIL; WARFARIN;

ARTICLE; BLEEDING; CATHETER ABLATION; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG DOSE REGIMEN; DRUG HALF LIFE; DRUG POTENTIATION; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HUMAN; INTERNATIONAL NORMALIZED RATIO; PATIENT EDUCATION; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; STROKE; THROMBOEMBOLISM;

EID: 33144466668     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2005.11.015     Document Type: Note

References (13)

1. P. Petersen G. Boysen Godtfredsen J, Anderson ED, Anderson B. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation The Copenhagen AFASAK studyLancet 1 1989 175-179
2. A.L. Gullov B.G. Koefoed P. Petersen T.S. Pedersen E.D. Anderson J. Godtfredsen Fixed mini-dose warfarin and aspirin alone and in combination vs. adjusted dose warfarin for stroke prevention in atrial fibrillation Second Copenhagen Atrial Fibrillation, Aspirin and Anticoagulation Study Arch Intern Med 158 1998 1513-1521
3. Stroke Prevention in Atrial Fibrillation Study. Final results Circulation 84 1991 527-539
4. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study Lancet 343 1994 687-691
5. Adjusted-dose warfarin versus low intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation Stroke Prevention in Atrial Fibrillation III randomised clinical trial Lancet 348 1996 633-638
6. The effect of low-dose warfarin on the risk for stroke in patients with non-rheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators N Engl J Med 323 1990 1505-1511
7. S.J. Connolly A. Laupacis M. Gent R.S. Roberts J.A. Cairns C. Joyner Canadian Atrial Fibrillation Anticoagulation (CAFA) Study J Am Coll Cardiol 18 1991 349-355
8. EAFT (European Atrial Fibrillation Trial) Study Group Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke Lancet 342 1993 1255-1262
9. M.J. Kovacs C. Kearon M. Rodger D.R. Anderson A.G. Turpie S.M. Bates L. Desjardins J. Douketis S.R. Kahn S. Solymoss P.S. Wells Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin Circulation 110 2004 1658-1663
10. G. Piazza S.Z. Goldhaber Periprocedural management of the anticoagulated patient critical pathways for bridging therapy Crit Pathways Cardiol 2 2003 96-103
11. http://coumadin.com. Last accessed October 19, 2005.
12. J.E. Marine S.Z. Goldhaber Controversies surrounding long-term anticoagulation of very elderly patients in atrial fibrillation Chest 113 1998 1115-1118
13. Micromedix. http://www.thomsonhc.com/hcs/librarian. Last accessed October 19, 2005.